Cargando…

Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway

Previous studies have indicated that stiehopus japonieus acidic mucopolysaccharide (SJAMP) could inhibit the proliferation of pancreatic cancer cell SW1990. However, the mechanism remains unclear. In our study, YAP expression was identified by immunohistochemistry and quantitative Real-time PCR from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoyu, Liu, Yi, Zhang, Cuiping, Niu, Qinghui, Wang, Hui, Che, Cong, Xie, Man, Zhou, Bin, Xu, Yonghong, Zhang, Qi, Wu, Jun, Tian, Zibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369968/ https://www.ncbi.nlm.nih.gov/pubmed/28099921 http://dx.doi.org/10.18632/oncotarget.14633

Ejemplares similares

Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell
por: Li, Xiaoyu, et al.
Publicado: (2018)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

MUCOPOLYSACCHARIDES PRODUCED IN TISSUE CULTURE
por: Grossfeld, Henry, et al.
Publicado: (1957)

The Biochemistry of Mucopolysaccharides of Connective Tissue
por: Lukens, Lewis N.
Publicado: (1962)

Innate Immunity in Mucopolysaccharide Diseases
por: Mandolfo, Oriana, et al.
Publicado: (2022)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

LncRNA PVT1 Promotes Cell Proliferation, Invasion, and Migration and Inhibits Cell Apoptosis by Phosphorylating YAP
por: Ji, Kaiyue, et al.
Publicado: (2022)

INHIBITION OF THEILER'S ENCEPHALOMYELITIS VIRUS (GDVII STRAIN) OF MICE BY AN INTESTINAL MUCOPOLYSACCHARIDE : II. PURIFICATION AND PROPERTIES OF THE MUCOPOLYSACCHARIDE
por: Mandel, Benjamin, et al.
Publicado: (1953)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Mucopolysaccharides in Peripheral Leucocytes of Cancer Patients
por: Riesco, Andres, et al.
Publicado: (1971)

METABOLISM OF ACID MUCOPOLYSACCHARIDES IN THE SHWARTZMAN PHENOMENON
por: Berenson, Gerald S., et al.
Publicado: (1960)

INHIBITION OF SYNTHESIS OF SULFATED MUCOPOLYSACCHARIDES BY ESTRADIOL
por: Priest, Robert E., et al.
Publicado: (1962)

The role of innate immunity in mucopolysaccharide diseases
por: Parker, Helen, et al.
Publicado: (2018)

Delivering gene therapy for mucopolysaccharide diseases
por: Wood, Shaun R., et al.
Publicado: (2022)

SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
por: Shen, Hengyang, et al.
Publicado: (2021)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
por: Mia, Masum M., et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

S.W. Radiologists Association: Meeting at Gloucester in October 1990
Publicado: (1991)

The Genetic Origin of Leucocytic Mucopolysaccharides in Cancer Patients
por: Riesco, A., et al.
Publicado: (1973)

The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response
por: Zheng, Ancheng, et al.
Publicado: (2022)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)

YAP–VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP
por: Cai, Jing, et al.
Publicado: (2022)

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023)

WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease
por: Zhang, Qi, et al.
Publicado: (2016)

PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway
por: Gu, Jiayi, et al.
Publicado: (2019)

microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions
por: Zhang, Tianqi, et al.
Publicado: (2020)

Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
por: Zhao, Xiaoguang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_54mgvstblte04blk6a2c933aun